A 5-Year Longitudinal, Multicentre Validation Study Assessing the Prognostic Value of Plasma Fibronectin in a Cohort of Parkinson's Disease Participants

Shuzhen Zhu(Hubei Provincial Center for Disease Control and Prevention), Zhenchao Xie(Zhujiang Hospital), Shujuan Yang(Sichuan University), Wenbiao Xian(Sun Yat-sen University), Fanheng Huang(Zhujiang Hospital), Rongfang Que(Zhujiang Hospital), Ling Ling Chan(Singapore General Hospital), Zihan Chang(Zhujiang Hospital), Hongzhen Xu(Hubei University of Medicine), К. Ray Chaudhuri(NIHR Maudsley Dementia Biomedical Research Unit), Chao Deng(University of Wollongong), Eng‐King Tan(SingHealth), Yi‐Heng Zeng(Zhujiang Hospital), Hualin Li(City University of Hong Kong), Zifeng Huang(Guangzhou University of Chinese Medicine), Minzi Li(Guangzhou First People's Hospital), Lucia Batzu(King's College Hospital NHS Foundation Trust), Guixia Li(Hospital of Hebei Province), Lin Shi(Qingdao University), Yanran Liang(Sun Yat-sen University), Jianmin Huang(Hebei Medical University), Mengyan Li(Guangzhou First People's Hospital), Hang Zhou(Shanghai Jiao Tong University), Xiaobo Wei(Zhujiang Hospital), Ying Pan(Second Affiliated Hospital of Guangzhou Medical University), Chengwu Yang(University of Massachusetts Chan Medical School), Fen Xie(Ganzhou People's Hospital)
SSRN Electronic Journal
January 1, 2023
Cited by 0


Related Papers